HCV Alliance 2015-Session 2 (Seattle, WA)
June 24, 2015
Target Audience
This activity was developed for gastroenterologists, primary care physicians, and health care professionals in the primary care field who manage patients with HCV and wish to improve their standard practice of care.
Learning Objectives
- Discuss currently approved FDA-approved regimens and the AASLD/IDSA HCV guidance document
- Describe clinical trial data and post-trial experience with approved regimens
- Analyze and discuss treatment algorithms in order to maximize patient outcomes
- Assess reimbursement issues and overcoming barriers to care
Seattle, WA
United States
Available Credit
- 1.50 AMA PRA Category 1 Credit(s)™
- 1.50 Attendance
- 1.50 CA-BRN
- 1.50 ANCC